The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $135.25

Today's change-2.66 -1.93%
Updated February 5 4:01 PM EST. Delayed by at least 15 minutes.
 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $135.25

Today's change-2.66 -1.93%
Updated February 5 4:01 PM EST. Delayed by at least 15 minutes.

Becton Dickinson and Co down (U.S.)$2.66

Becton Dickinson and Co closed sharply lower Friday, dropping (U.S.)$2.66 or 1.93% to (U.S.)$135.25. Over the last five days, shares have lost 6.96% and sit 4.95% above their 52-week low. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $137.50
  • Previous close(U.S.) $137.91
  • High(U.S.) $137.95
  • Low(U.S.) $134.71
  • Bid / Ask-- / --
  • YTD % change-12.23%
  • Volume1,227,482
  • Average volume (10-day)1,378,893
  • Average volume (1-month)1,301,035
  • Average volume (3-month)1,101,068
  • 52-week range(U.S.) $128.87 to (U.S.) $157.50
  • Beta1.02
  • Trailing P/E39.78×
  • P/E 1 year forward16.09×
  • Forward PEG1.21×
  • Indicated annual dividend(U.S.) $2.64
  • Dividend yield1.95%
  • Trailing EPS(U.S.) $3.40
Updated February 5 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.75%

Based on its net profit margin of 6.75%, Becton Dickinson and Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue3,0603,1202,0512,051
Total other revenue--------
Total revenue3,0603,1202,0512,051
Gross profit1,4161,1881,0461,045
Total cost of revenue1,6441,9321,0051,006
Total operating expense2,7652,9831,7581,702
Selling / general / administrative743764511544
Research & development195178129129
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)18210811323
Other operating expenses, total11----
Operating income295137293349
Interest income (expense), net non-operating-99-105-91-76
Gain (loss) on sale of assets--------
Other--------
Income before tax19039225285
Income after tax18162216235
Income tax, total9-23950
Net income18162216235
Total adjustments to net income------1
Net income before extra. items18162216235
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items18162216236
Inc. avail. to common incl. extra. items18162216236
Diluted net income18162216236
Dilution adjustment------0
Diluted weighted average shares217215200197
Diluted EPS excluding extraordinary itemsvalue per share0.830.291.081.20
Dividends per sharevalue per share0.600.600.600.60
Diluted normalized EPSvalue per share1.630.621.621.29